Examination of the Effects of Financial Risk on the Formal Treatment Costs for a Medicaid Population With Psychiatric Disabilities
Bibliographic Data
| ID | 9099376 |
|---|---|
| Authors | Kristine Jones (Nathan Kline Institute for Psychiatric Research, corresponding author), Huey Jen Chen (University of South Florida), Neil Jordan (0000-0001-8467-822X, FrontLine Service), Roger A Boothroyd (0000-0003-3344-5746, University of South Florida), Josefa Ramoni-Perazzi, Josefá Ramoni Perazzi (0000-0002-0493-1940), David L Shern (University of South Florida) |
| Year | 2006 |
| Volume | 44 |
| Issue | 4 |
| Pages | 320-327 |
| Publication date | 2006-04-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000204302.26073.13 |
| PMID | 16565632 |
| OpenAlex | W2021138327 |
| Language | EN |
| Citations received | 4 |
| References cited | 26 |
OBJECTIVES: We examined the effects of differing financial risk arrangements for mental health, physical health, and pharmacy services on the overall costs of these services with particular attention to cost containment and cost shifting. METHODS: Comprehensive service utilization information was obtained from a sample of 458 adults with severe mental illnesses during a 12-month period. Rate information was used to calculate costs for health, mental health and pharmacy. A 2-part model was employed to test for differences among financial risk conditions. RESULTS: Total treatment costs, both those financed by Medicaid and those paid by other sources, were lower in plans that had a broader array of services for which they were at risk. Pharmacy costs were principally responsible for these differences. CONCLUSIONS: Treatment costs for adults with severe mental illnesses can be contained by placing providers at financial risk. However, risk arrangements may also increase treatment costs borne by other payers including charity services and self-pay. Evaluating the impact of at-risk financing mechanisms from a public health perspective requires assessing cost shifting, particularly for pharmaceuticals
Actuarial science · Business · Economics · Environmental health · Health care · Medicaid · Population · Psychiatry · Finance · Health Systems, Economic Evaluations, Quality of Life · Healthcare Policy and Management · Medicine · Schizophrenia research and treatment
| Unique citing works | 4 |
|---|---|
| Citations per year | 0,2 |
| Citation span | 2006 - 2019 (14) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 2 |